Zobrazeno 1 - 10
of 320
pro vyhledávání: '"L. B. Lazebnik"'
Publikováno v:
Фармакоэкономика, Vol 16, Iss 3, Pp 432-446 (2023)
Background. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 of patients with nonalcoholic fatty liver disease (NAFLD), manifestations of hyperferritinemia are revealed. Increased ferritin level indicates the severity
Externí odkaz:
https://doaj.org/article/e714a9a9983e41a8963c02e6cec3589e
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 8, Iss 3, Pp 69-77 (2009)
Aim. To study clinical, functional, morphological and pharmacological features of hepatic pathology in patients with non-alcohol hepatic steatosis (NAHS), combined with atherogenic dyslipidemia (ADL) and/or insulin resistance (IR).Material and method
Externí odkaz:
https://doaj.org/article/7ce827398b03452fb06b3cc0922ba14c
Autor:
O. A. Kamyshansky, S. T. Ignatova, G. O. Treneva, I. V. Shchenyatskaya, A. A. Ryabov, L. B. Lazebnik
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 7, Iss 3, Pp 83-88 (2008)
Aim. To study the prevalence of selected cardiovascular risk factors in young people with arterial hypertension (AH) and high normal blood pressure (HNBP), to clarify primary AH prevention strategies.Material and methods. The study included 2280 stud
Externí odkaz:
https://doaj.org/article/7a2a7c8bade249bd8c0b8f1d15fd21f8
Autor:
L. B. Lazebnik, I. A. Komissarenko
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 82-87 (2006)
Externí odkaz:
https://doaj.org/article/8e176349c2c943b48eded5a9fe1b254e
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 30-33 (2006)
Externí odkaz:
https://doaj.org/article/9e93d9bc01594931af88274419a633af
Autor:
L. B. Lazebnik, E. A. Shutemova, I. A. Komissarenko, Yu. V. Kadnikova, O. A. Maslennikova, E. A. Petrunina, O. A. Nazarova
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 10-13 (2004)
The aim of the study was to compare 24-hour blood pressure (BP) profile in elderly patients with borderline arterial hypertension (BAH) and in subjects with more advanced AH stages. Ninety-nine elderly pateints (mean age 72+4 years) were examined. Tw
Externí odkaz:
https://doaj.org/article/5109657eb6714ebfa8c457fb98e3868f
Autor:
L. B. Lazebnik, S. M. Gaynulin, V. N. Drozdov, I. V. Nazarenko, S. M. Pyatigorskaya, Yu. I. Karagodina
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 5-10 (2003)
Implementation measures on treatment of arterial hypertension in Moscow.
Externí odkaz:
https://doaj.org/article/6b8303a4e619437d868e5955f5db27d9
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 51-53 (2006)
Externí odkaz:
https://doaj.org/article/db83c8a9ff45491b82eae00a617d6a2d
Publikováno v:
КардиоСоматика, Vol 2, Iss 1-1, Pp 70-71 (2011)
В современных условиях проблема кардиологического обеспечения урологических оперативных вмешательств стоит достаточно остро, что свя
Externí odkaz:
https://doaj.org/article/8779039bae0648c4817576ca04636283
Publikováno v:
КардиоСоматика, Vol 2, Iss 1-1, Pp 69-70 (2011)
Цель исследования. Основываясь на фармакокинетических и фармакодинамических особенностях ингибиторов АПФ и р-адреноблокаторов оптими
Externí odkaz:
https://doaj.org/article/ae62ed97de34413cb124b927ec864c93